Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marisa Iborra

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Gastrointestinal Endoscopy Clinics of North America|September 17, 2016
Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel DiseaseMarisa Iborra, Belén Beltrán, Pilar Nos
Clinical and Experimental Gastroenterology|February 14, 2014
Long-term safety and efficacy of budesonide in the treatment of ulcerative colitisMarisa Iborra, Diego Alvarez-Sotomayor, Pilar Nos
Autoimmunity Reviews|July 15, 2010
MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune responseMarisa Iborra, Francesca Bernuzzi, Pietro Invernizzi, et al.
Journal of Crohn'S & Colitis|April 2, 2011
Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effectMarisa Iborra, Belén Beltrán, Guillermo Bastida, et al.
Clinical and Experimental Immunology|January 22, 2024
Catalase inhibition can modulate the ability of peripheral blood T cells to undergo apoptosis in Crohn's diseaseInés Moret-Tatay, Pilar Nos, Marisa Iborra, et al.
Oxidative Medicine and Cellular Longevity|January 30, 2016
Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs-Current Evidences and Further Aspects to UnravelInés Moret-Tatay, Marisa Iborra, Elena Cerrillo, et al.
Nutrients|May 15, 2019
Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD PatientsPedro López-Muñoz, Belén Beltrán, Esteban Sáez-González, et al.
Gastroenterologia Y Hepatologia|May 7, 2013
[Oxidative stress in Crohn's disease]Inés Moret, Elena Cerrillo, Ana Navarro-Puche, et al.
Gastroenterologia Y Hepatologia|February 17, 2025
High persistence rate at one year- follow-up of subcutaneous vedolizumab at standard dose after switching endovenous vedolizumab, even in those previously intensified: results of a Spanish multicentre observational studyLaura Andrés, Marisa Iborra, Raquel Vicente, et al.
Nutrients|May 15, 2019
Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel DiseaseEsteban Sáez-González, Beatriz Mateos, Pedro López-Muñoz, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Gastrointestinal Endoscopy Clinics of North America|September 17, 2016
Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel DiseaseMarisa Iborra, Belén Beltrán, Pilar Nos
Clinical and Experimental Gastroenterology|February 14, 2014
Long-term safety and efficacy of budesonide in the treatment of ulcerative colitisMarisa Iborra, Diego Alvarez-Sotomayor, Pilar Nos
Autoimmunity Reviews|July 15, 2010
MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune responseMarisa Iborra, Francesca Bernuzzi, Pietro Invernizzi, et al.
Journal of Crohn'S & Colitis|April 2, 2011
Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effectMarisa Iborra, Belén Beltrán, Guillermo Bastida, et al.
Clinical and Experimental Immunology|January 22, 2024
Catalase inhibition can modulate the ability of peripheral blood T cells to undergo apoptosis in Crohn's diseaseInés Moret-Tatay, Pilar Nos, Marisa Iborra, et al.
Oxidative Medicine and Cellular Longevity|January 30, 2016
Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs-Current Evidences and Further Aspects to UnravelInés Moret-Tatay, Marisa Iborra, Elena Cerrillo, et al.
Nutrients|May 15, 2019
Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD PatientsPedro López-Muñoz, Belén Beltrán, Esteban Sáez-González, et al.
Gastroenterologia Y Hepatologia|May 7, 2013
[Oxidative stress in Crohn's disease]Inés Moret, Elena Cerrillo, Ana Navarro-Puche, et al.
Gastroenterologia Y Hepatologia|February 17, 2025
High persistence rate at one year- follow-up of subcutaneous vedolizumab at standard dose after switching endovenous vedolizumab, even in those previously intensified: results of a Spanish multicentre observational studyLaura Andrés, Marisa Iborra, Raquel Vicente, et al.
Nutrients|May 15, 2019
Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel DiseaseEsteban Sáez-González, Beatriz Mateos, Pedro López-Muñoz, et al.
Pageof 10